V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037283 | 210007796 | 0 | 10.8 | Curative (C) | 2015-05-01 | 2015-05-30 | null | 1 | N | 210014054 | NOT MATCHED |
| 210037284 | 210019149 | null | 14.7 | Curative (C) | 2016-08-04 | 2016-08-10 | CNS PNET 5 Medbl L/StRsk Mnt B | N | N | 210014068 | NOT MATCHED |
| 210037285 | 210030538 | 1.08 | 18.2 | Curative (C) | 2015-02-14 | 2015-02-13 | CNS Epen2007 09 Baby Brn vinc+Mtx | N | null | 210014072 | NOT MATCHED |
| 210037286 | 210007822 | 0.95 | 9.9 | Curative (C) | 2018-11-17 | 2018-12-16 | CNS Headstart II A Ind 1,2,3 int | 1 | N | 210014084 | NOT MATCHED |
| 210037287 | 210007842 | null | 9.2 | Disease modification (D) | 2017-11-29 | 2018-03-16 | null | 02 | N | 210014139 | NOT MATCHED |
| 210037288 | 210026291 | 1.81 | 28.8 | Curative (C) | 2016-07-08 | 2016-10-21 | AML Interim Guidelines FLA | null | N | 210014166 | NOT MATCHED |
| 210037289 | 210007858 | null | 40.6 | Curative (C) | 2014-07-10 | 2014-07-17 | IDARUBICIN + IMATINIB + VINCRISTINE | N | N | 210014168 | NOT MATCHED |
| 210037290 | 210007879 | null | 8.9 | Curative (C) | 2018-03-18 | 2018-08-26 | ALL ALLR3: Maint Wk 1-12 wth IT Mtx | 2 | Y | 210014253 | NOT MATCHED |
| 210037291 | 210019174 | 1.76 | null | Curative (C) | 2017-02-20 | 2017-02-22 | ALL UKALL2011 Del Int C Recon Erw | N | null | 210014260 | NOT MATCHED |
| 210037292 | 210007892 | null | 15.25 | Palliative (P) | 2017-02-28 | 2017-02-28 | CNS LGG | Y | null | 210014273 | NOT MATCHED |
| 210037293 | 210007900 | 0 | 8.3 | Curative (C) | 2015-04-20 | 2015-06-15 | CNS Ependymoma II Vinc/Cyclophos + valproate | N | N | 210014286 | NOT MATCHED |
| 210037294 | 210007907 | 1.76 | 80 | Palliative (P) | 2016-08-07 | 2016-12-28 | PCV | null | null | 210014295 | PCV |
| 210037295 | 210007916 | 1.57 | 45.2 | Adjuvant (A) | 2014-12-05 | 2014-12-12 | PCV | N | N | 210014311 | PCV |
| 210037296 | 210034864 | null | 103.7 | Palliative (P) | null | 2016-06-19 | PCV | N | N | 210014314 | PCV |
| 210037297 | 210007928 | 1.68 | 62.9 | Palliative (P) | 2017-10-05 | 2017-10-10 | PCV | 02 | N | 210014320 | PCV |
| 210037298 | 210007948 | 1.63 | 69.6 | Palliative (P) | 2015-11-02 | 2015-11-18 | PCV | 02 | N | 210014387 | PCV |
| 210037299 | 210030545 | 1.57 | 103 | Palliative (P) | 2014-01-21 | 2015-01-04 | PCV | N | N | 210014446 | PCV |
| 210037300 | 210007969 | 1.83 | null | Palliative (P) | 2016-11-26 | 2017-01-13 | PCV | null | null | 210014450 | PCV |
| 210037302 | 210007980 | 1.7 | 92.9 | Curative (C) | 2015-07-09 | 2015-07-24 | Temozolomide + RT | N | null | 210014466 | TEMOZOLOMIDE + RT |
| 210037303 | 210007990 | null | null | Curative (C) | 2013-08-23 | 2013-09-28 | Temozolomide + RT | N | N | 210014481 | TEMOZOLOMIDE + RT |
| 210037304 | 210008000 | 1.81 | null | Curative (C) | 2018-04-14 | 2018-04-28 | Temozolomide + RT | N | N | 210014497 | TEMOZOLOMIDE + RT |
| 210037305 | 210008021 | 1.87 | 94 | null | 2016-05-03 | 2016-07-31 | Trial Unspecified | null | null | 210014510 | TRIAL |
| 210037306 | 210008032 | 0 | 52.7 | Curative (C) | null | 2016-04-18 | Trial Unspecified | 2 | N | 210014519 | TRIAL |
| 210037307 | 210019219 | 1.5 | null | Palliative (P) | null | 2019-06-23 | Trial Unspecified | Y | N | 210014561 | TRIAL |
| 210037308 | 210008051 | null | null | Curative (C) | 2015-11-18 | 2015-12-16 | Temozolomide + RT | N | Y | 210014576 | TEMOZOLOMIDE + RT |
| 210037309 | 210008061 | null | 50 | Palliative (P) | 2015-11-12 | 2015-11-19 | Temozolomide + RT | N | null | 210014595 | TEMOZOLOMIDE + RT |
| 210037312 | 210008091 | 1.57 | null | Curative (C) | 2014-05-25 | 2014-06-08 | Temozolomide + RT | N | N | 210014651 | TEMOZOLOMIDE + RT |
| 210037314 | 210019244 | null | 82 | null | 2019-02-23 | 2019-02-24 | Trial Unspecified | 01 | N | 210014674 | TRIAL |
| 210037315 | 210008135 | 0.92 | null | Disease modification (D) | 2014-11-24 | 2014-12-29 | Temozolomide + RT | N | N | 210014747 | TEMOZOLOMIDE + RT |
| 210037316 | 210019258 | 1.63 | 48.5 | Curative (C) | 2018-03-14 | 2018-03-14 | CNS Medbl HR Cyclo+Vinc | Y | N | 210014775 | TRIAL |
| 210037318 | 210019270 | null | 0 | Curative (C) | 2017-03-13 | 2017-04-10 | Trial Unspecified | Y | N | 210014839 | TRIAL |
| 210037319 | 210030558 | 1.79 | 73.2 | Curative (C) | 2015-09-04 | 2017-05-12 | Rituximab | N | N | 210014841 | RITUXIMAB |
| 210037320 | 210008216 | 1.68 | 16.5 | Palliative (P) | 2018-08-01 | 2018-08-02 | Lomustine | N | N | 210014930 | LOMUSTINE |
| 210037321 | 210008246 | 1.7 | 69 | Palliative (P) | null | 2019-02-25 | Lomustine | N | N | 210015020 | LOMUSTINE |
| 210037322 | 210008269 | 1.72 | 90.2 | Disease modification (D) | 2014-03-14 | 2014-09-05 | Rituximab | N | N | 210015070 | RITUXIMAB |
| 210037323 | 210008275 | null | null | Palliative (P) | 2015-01-30 | 2015-01-30 | Lomustine | N | N | 210015090 | LOMUSTINE |
| 210037324 | 210008285 | null | null | Palliative (P) | 2014-01-17 | 2014-01-17 | IBRUTINIB | N | N | 210015114 | IBRUTINIB |
| 210037325 | 210008301 | 1.77 | 70.9 | Palliative (P) | 2018-11-16 | 2019-05-24 | Lomustine | 02 | N | 210015173 | LOMUSTINE |
| 210037326 | 210008307 | 1.59 | 66.35 | Curative (C) | 2016-01-01 | 2016-04-03 | Rituximab | Y | N | 210015192 | RITUXIMAB |
| 210037327 | 210008318 | 1.59 | null | Disease modification (D) | 2016-02-23 | 2016-04-14 | IBRUTINIB | N | N | 210015206 | IBRUTINIB |
| 210037328 | 210008324 | null | 114 | Disease modification (D) | 2016-09-13 | 2017-03-14 | IBRUTINIB | N | N | 210015216 | IBRUTINIB |
| 210037329 | 210008332 | 1.81 | 84.8 | Curative (C) | 2014-12-13 | 2015-07-19 | Rituximab | N | N | 210015220 | RITUXIMAB |
| 210037330 | 210008339 | 1.79 | 80 | Curative (C) | 2015-06-21 | 2015-06-21 | Rituximab | null | null | 210015224 | RITUXIMAB |
| 210037331 | 210026419 | 1.72 | null | Palliative (P) | 2018-06-22 | 2018-06-22 | IBRUTINIB | N | N | 210015258 | IBRUTINIB |
| 210037332 | 210008362 | 1.54 | 85.45 | Palliative (P) | 2016-04-04 | 2016-04-07 | Lomustine | 02 | N | 210015268 | LOMUSTINE |
| 210037333 | 210008368 | null | 59.4 | null | 2018-01-30 | 2018-01-30 | Rituximab | N | N | 210015285 | RITUXIMAB |
| 210037334 | 210008383 | 1.55 | 63 | Curative (C) | 2017-03-07 | 2017-03-07 | Bendamustine+Rituximab(Sub Courses) | N | Y | 210015310 | BENDAMUSTINE + RITUXIMAB |
| 210037335 | 210008398 | 1.88 | 0 | Palliative (P) | 2014-12-01 | 2015-10-04 | FLAIR Trial | Y | N | 210015323 | FLAIR TRIAL |
| 210037336 | 210008462 | null | 83.3 | Curative (C) | null | 2013-12-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 210015471 | BENDAMUSTINE + RITUXIMAB |
| 210037337 | 210008469 | 1.76 | 77.8 | Curative (C) | 2016-12-28 | 2017-04-04 | VINCRISTINE | null | N | 210015487 | VINCRISTINE |